Extended surveillance to assess safety of 9-valent human papillomavirus vaccine

The safety of 9-valent HPV vaccine (9vHPV) has been established with regard to common and uncommon adverse events. However, investigation of rare and severe adverse events requires extended study periods to capture rare outcomes. This observational cohort study investigated the occurrence of three r...

Descripción completa

Detalles Bibliográficos
Autores principales: Sundaram, Maria E., Kieke, Burney A., Hanson, Kayla E., Belongia, Edward A., Weintraub, Eric S., Daley, Matthew F., Hechter, Rulin C., Klein, Nicola P., Lewis, Edwin M., Naleway, Allison L., Nelson, Jennifer C., Donahue, James G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
HPV – Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891676/
https://www.ncbi.nlm.nih.gov/pubmed/36577134
http://dx.doi.org/10.1080/21645515.2022.2159215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891676/
https://www.ncbi.nlm.nih.gov/pubmed/36577134
http://dx.doi.org/10.1080/21645515.2022.2159215

Ejemplares similares